• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » OxiWear raises $1.25M for wearable pulse oximeter

OxiWear raises $1.25M for wearable pulse oximeter

November 17, 2021 By Sean Whooley

OxiWear
A prototype for OxiWear’s pulse oximeter device [Image courtesy of OxiWear]
Medtech and sports tech startup OxiWear announced today that it closed an oversubscribed pre-seed funding round at $1.25 million.

Arlington, Virginia–based OxiWear develops a wearable pulse oximeter that delivers 24-hour continuous oxygen monitoring and low-oxygen alerting. The $1.25 million in funding comes in at half a million more dollars than expected for the pre-seed funding round.

GAP Funds led the pre-seed round, with reinvestments coming from Ted Leonsis and The Paul & Rose Carter Foundation. Additionally, Paul Caicedo, Future Communities Capital, Gaingels, Halcyon Fund, Hourglass Venture Partners, TiE DC and Boston Chapters, and Tysons Angel Group contributed to the round, according to a news release.

A person wears OxiWear’s device on the ear, which the company said is one of the most accurate places to measure oxygen saturation levels (SPO2) and detect when oxygen levels begin to drop. The company, founded in 2019, said the device can provide accurate and reliable oxygen monitoring for performance athletes, high-altitude travelers and patients prone to silent hypoxia.

“OxiWear is a product that I developed to help patients like me — those living with pulmonary hypertension,” OxiWear founder and CEO Shavini Fernando said in the news release. “Through our research, we learned that there is a larger market for oxygen monitoring including elite athletes, high-altitude travelers, and patients with diseases such as COPD, sleep apnea and COVID-19.”

The company said the funding will allow it to finalize its go-to-market product development and initiate beta testing for its consumer device, with eyes on a launch by mid-2022. OxiWear is currently completing pre-submission meetings with the FDA for its medical device designation.

“I’ve been a proud, early supporter of Shavini and her life-saving work, and I congratulate her on not only meeting her pre-seed funding round target — but decisively beating it,” said Leonsis, the owner of sports franchises such as the Washington Wizards, Mystics and Capitals. “It’s a testament to how in-demand her product is and how smartly she has built her company around it. I expect she will only continue to grow, and I happily stand by her to offer advice whenever she needs it.”

Filed Under: Business/Financial News, Diagnostics, Digital Health, Featured, Funding Roundup, News Well, Patient Monitoring Tagged With: OxiWear

More recent news

  • BD files patent infringement lawsuit against Baxter over infusion pump tech
  • Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set
  • Apreo Health emerges from stealth with positive data for lung scaffold
  • Tivic adds new vagus nerve stim patent
  • Study backs Teleflex stapler for reducing post-op GERD rates

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy